MAS
75
4
CSX
55
11
MSI
58
3
EQR
45
-2
NSC
51
-2
TSN
44
-3
ADT
74
5
CNP
52
2
MO
42
-6
RIG
14
-5
LLY
68
3
PVH
34
-10
GOOG
65
4
MNST
46
-3
NI
50
2
DUK
45
3
ICE
55
2
AON
69
4
STX
71
-3
PBI
42
-3
MAS
75
4
CSX
55
11
MSI
58
3
EQR
45
-2
NSC
51
-2
TSN
44
-3
ADT
74
5
CNP
52
2
MO
42
-6
RIG
14
-5
LLY
68
3
PVH
34
-10
GOOG
65
4
MNST
46
-3
NI
50
2
DUK
45
3
ICE
55
2
AON
69
4
STX
71
-3
PBI
42
-3
Financhill
Back

ARK Innovation ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
97

ARKK
ARK Innovation ETF

Last Price:
$73.30
Seasonality Move:
-2.01%
Sell
37

APLS
Apellis Pharmaceuticals

Last Price:
$19.32
Seasonality Move:
-16.64%
Buy
97
ARK Innovation ETF (ARKK) is a Buy

Is ARK Innovation ETF a Buy, Sell or Hold?

  • The current ARK Innovation ETF [ARKK] share price is $72.37. The Score for ARKK is 97, which is 94% above its historic median score of 50, and infers lower risk than normal.
  • ARKK is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
37
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $19.21. The Score for APLS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARKK Stock Price Chart

What is ARK Innovation ETF's stock price today?

  • The ARK Innovation ETF share price today is $72.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARKK is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $19.21
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

ARKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.37 Buy
Relative Strength Index (14 RSI): 71 Buy
Chaikin Money Flow: 8120019 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (61.47 - 70.85) Buy
Bollinger Bands (100): (47.82 - 64.04) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 57.88 Buy
Chaikin Money Flow: 3142813 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.69 - 19.09) Buy
Bollinger Bands (100): (17.14 - 24.36) Sell

ARKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70.56 Buy
20-day SMA: 67.91 Buy
50-day SMA: 60.3 Buy
200-day SMA: 55.29 Buy
8-day EMA: 70.58 Buy
20-day EMA: 67.73 Buy
50-day EMA: 62.23 Buy
200-day EMA: 55.41 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.9 Buy
20-day SMA: 18.23 Buy
50-day SMA: 18.18 Buy
200-day SMA: 25.58 Sell
8-day EMA: 18.16 Buy
20-day EMA: 18.15 Buy
50-day EMA: 18.77 Buy
200-day EMA: 25.96 Sell

ARK Innovation ETF Earnings Growth & ARKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.23 per share, and an increase next year of $0.73 per share.

ARK Innovation ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):